8049 — Jilin Province Huinan Changlong Bio-pharmacy Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Market Cap
HK$1.06bn
Enterprise Value
HK$567.72m
Revenue
CNY881.16m

Annual income statement for Jilin Province Huinan Changlong Bio-pharmacy Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	622	705	842	842	881
Cost of Revenue
Gross Profit	531	580	648	584	685
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	471	528	644	643	672
Operating Profit	151	178	198	199	209
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	150	177	197	198	207
Provision for Income Taxes
Net Income After Taxes	127	143	194	148	184
Net Income Before Extraordinary Items
Net Income	127	143	194	148	184
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	127	143	194	148	184
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.227	0.256	0.373	0.272	0.329
Special Dividends per Share